Saturday, 30 May 2020

COVID-19 : reminder of the risks of chloroquine and hydroxychloroquine

EMA is reminding healthcare professionals to closely monitor patients with COVID-19 who are receiving chloroquine or hydroxychloroquine, given the serious side effects that can result from treatment with these medicines.



source https://www.pharmatutor.org/content/may-2020/covid-19-reminder-of-the-risks-of-chloroquine-and-hydroxychloroquine

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...